Kerry aims to acquire part of Chr. Hansen and Novozymes’ lactase enzyme business

News
Article

The acquisition would give Kerry additional technology to create lactose-free and reduced-sugar dairy products.

Photo © AdobeStock.com/Anastasiia

Photo © AdobeStock.com/Anastasiia

Kerry Group plc (Tralee, Ireland) announced plans to acquire part of the global lactase enzyme business belonging to Chr. Hansen Holding A/S and Novozymes A/S.

“The acquisition is subject to European Commission approval of Kerry as a buyer and forms part of the Novozymes and Chr. Hansen merger-approval process,” Kerry’s press release notes.

The acquisition would boost Kerry’s enzyme technology to create lactose-free and reduced-sugar dairy products, the firm says. Kerry had already acquired enzyme manufacturers c-LEcta and Enmex. This latest acquisition would further bolster the company’s biotechnology capabilities.

Related Videos
woman working on laptop computer by window
© 2024 MJH Life Sciences

All rights reserved.